Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers. Prognostic significance of p53 expression in advanced-stage ovarian serous borderline tumors.
Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells.
Abstract Related articles October 1999 MAHE MA, Fumoleau P, Fabbro M, et al. Abstract Related articles ARTS HJ, Katsaros D, de Vries EG, et al. Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.